Document is current
Any future updates will be listed below
-
Authors
Tapper, Elliot B.
Krieger, Nancy
Przybysz, Raymond
Way, Nate
Cai, Jennifer
Zappe, Dion
McKenna, Sarah Jane
Wall, Garth
Janssens, Nico
Balp, Maria-Magdalena
- License Information
-
More Information
Article History
Received: 25 January 2022
Accepted: 14 March 2023
First Online: 5 April 2023
Declarations
:
: The Pearl Institutional Review Board assessed the NHWS and awarded it exemption. The analyses were carried out in accordance with recognized published methodologies. All respondents viewed an on-line informed consent form and indicated their consent to participate prior to responding to the survey.
: Not applicable.
: Elliot B. Tapper received a consultancy fee for his medical expertise on this project from Novartis Pharmaceuticals Corp., US. Maria-Magdalena Balp and Nico Janssens are employees of Novartis Pharma AG, Basel, Switzerland. Nate Way is an employee of Cerner Enviza (formally Kantar Health), Raymond Przybysz and Jennifer Cai are employees of Novartis Pharmaceuticals Corp., US, and Sarah Jane McKenna is an employee of Novartis Business Services Centre, Ireland.Nancy Krieger, Dion Zappe and Garth Wall were employees of Novartis Pharmaceuticals Corp., US at the time of the study and the initial development of the manuscript.
